Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02951689
Other study ID # 16-1397
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2016
Est. completion date January 2018

Study information

Verified date September 2018
Source University of North Carolina, Chapel Hill
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Purpose: To evaluate the influence of probiotic supplementation on body composition and other markers of health in occupational shift-workers.

Participants: Healthy, overweight females (ages 22-55 yrs) who are employed on a shift-working schedule.

Procedures (methods): In a randomized, placebo-controlled intervention, subjects will complete 3 different testing sessions (pre-screening, 1 baseline, 1 post-testing session) as well as a 6-week intervention period. Prescreening will include written informed consent, a health history questionnaire, baseline anthropometric measures, assessment of resting heart rate, and exercise protocol familiarization. Baseline testing will involve body composition, a fasted blood draw, mood surveys, and an exercise treadmill test. Subjects will be randomized to a treatment group (multi-strain probiotic or placebo) for 6 weeks of supplementation that includes 2 electronic contacts, followed by post-testing that will occur in the same fashion as baseline testing.


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date January 2018
Est. primary completion date January 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 22 Years to 55 Years
Eligibility Inclusion Criteria:

- Healthy, pre-menopausal women

- Currently employed on a shift-working (rotating, evening, or night) schedule and has maintained this schedule = 6 months prior to enrollment

- Participant agrees to maintain usual activity lifestyle

- Participant has a body mass index of =25 kg/m2

- Participant has provided written and dated informed consent to participate in the study

- Participant is willing and able to comply with the protocol

- Participant is apparently healthy and free from disease, as determined by a health history questionnaire

- Participant agrees to abstain from smoking, caffeine, tobacco, and alcohol before testing days

- Participant is not currently pregnant and does not desire to become pregnant in the next 8 weeks.

Exclusion Criteria:

- Having a history of medical or surgical events that may significantly affect the study outcome, including cardiovascular disease, metabolic, renal, hepatic, or musculoskeletal disorders

- Participant is using, or has used a probiotic supplements within 8 weeks prior to enrollment

- Participant has lost or gained greater than 8 pounds within the previous 2 months

- Participant is in, or has participated in another clinical trial within 4 weeks prior to enrollment

- Participant had or currently has a self-identified eating disorder

- Participant is pregnant or plans on becoming pregnant

- Participant has a known allergy or sensitivity to any ingredient in the test product or placebo (determined from health history questionnaire)

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Probiotic

Placebo


Locations

Country Name City State
United States Applied Physiology Laboratory Chapel Hill North Carolina

Sponsors (3)

Lead Sponsor Collaborator
University of North Carolina, Chapel Hill National Strength and Conditioning Association Foundation, Winclove Probiotics

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visceral Fat measured by ultrasound 6 weeks
Secondary Ratio of fat in the abdominal region vs. hip region Measured from dual energy x-ray absorptiometry 6 weeks
Secondary Body Fat measured from dual energy x-ray absorptiometry 6 weeks
Secondary Lean body mass measured from dual energy x-ray absorptiometry 6 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1